Bebtelovimab
(asked on 13th June 2022) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, Whether the mAbs drug Beblitovimab is under consideration for purchase by his Department.
This question was answered on 21st June 2022
The Antivirals and Therapeutics Taskforce is working with the RAPID-C19 Collaborative to review clinical trials data for COVID-19 treatments. Bebtelovimab and other monoclonal antibodies are being reviewed as part of this process. However, Bebtelovimab is not currently under consideration for procurement as it has yet to receive regulatory approval for use in the United Kingdom.